Neurocrine Biosciences, Inc.
NBIX
Market Cap$10.03B
Close$
$267.93
166.1% upside
Current Fair Value
166.1% upsideUndervalued by 166.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $10.03 Billion |
|---|---|
| Enterprise Value | $10.25 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $3.4 |
| Beta | 0.33 |
| Outstanding Shares | 100,400,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 29.82 |
|---|---|
| PEG | -98.76 |
| Price to Sales | 4.38 |
| Price to Book Ratio | 4.03 |
| Enterprise Value to Revenue | 4.35 |
| Enterprise Value to EBIT | 17.69 |
| Enterprise Value to Net Income | 30 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Neurocrine Biosciences, Inc.
CEO: Kevin Gorman